SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-059508
Filing Date
2020-05-11
Accepted
2020-05-11 16:01:56
Documents
14
Period of Report
2020-05-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2018626d6_8k.htm   iXBRL 8-K 30868
2 EXHIBIT 99.1 tm2018626d6_ex99-1.htm EX-99.1 52212
6 GRAPHIC tm2018626d6_ex99-1img01.jpg GRAPHIC 4170
  Complete submission text file 0001104659-20-059508.txt   275469

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ptla-20200511.xsd EX-101.SCH 3183
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ptla-20200511_lab.xml EX-101.LAB 34591
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ptla-20200511_pre.xml EX-101.PRE 22708
9 EXTRACTED XBRL INSTANCE DOCUMENT tm2018626d6_8k_htm.xml XML 3487
Mailing Address 270 EAST GRAND AVENUE, SUITE 22 SOUTH SAN FRANCISCO CA 94080
Business Address 270 EAST GRAND AVENUE, SUITE 22 SOUTH SAN FRANCISCO CA 94080 650-244-6864
PORTOLA PHARMACEUTICALS INC (Filer) CIK: 0001269021 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35935 | Film No.: 20864658
SIC: 2834 Pharmaceutical Preparations